A 37-year-old Menkes disease patient—Residual ATP7A activity and early copper administration as key factors in beneficial treatment

journal contribution

posted on 2024-06-03, 16:34 authored by Z Tümer, M Petris, S Zhu, Julian MercerJulian Mercer, J Bukrinski, S Bilz, K Baerlocher, N Horn, LB Møller

A 37-year-old Menkes disease patient—Residual ATP7A activity and early copper administration as key factors in beneficial treatment

History

Journal

Clinical Genetics

Volume

92

Pagination

548-553

Location

London, Eng.

ISSN

0009-9163

eISSN

1399-0004

Language

eng

Publication classification

C1 Refereed article in a scholarly journal

Issue

5

Publisher

Wiley

Usage metrics

Categories

Keywords

ATP7A copper copper metabolism copper treatment copperhistidine Genetics & Heredity HISTIDINE THERAPY INDUCED TRAFFICKING Life Sciences & Biomedicine Menkes disease residual function Science & Technology

Licence

All Rights Reserved

Exports